During his remarks in a House hearing last month, Representative Sanford Bishop grilled OMB director Russell Vought over ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

This summer, President Donald Trump has begun to chisel back Medicaid and food stamps. On a July day in 1965, President ...

A change to Medicaid’s retroactive coverage under the One Big Beautiful Bill Act will disproportionately impact seniors, who ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Donald Trump and Senate Republicans have released a sweeping proposal to overhaul Medicaid, introducing deeper spending cuts ...

A federal judge ruled that the policy violated the organization's First Amendment rights. But the Trump administration is ...

Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

U.S. Rep. Raul Ruiz holds forum with local health leaders to discuss President Trump's 'One Big Beautiful Bill' in Palm ...

The far-reaching impacts on Medicaid from President Trump's "big, beautiful bill" are coming into focus in Colorado, and ...

Shares of Eli Lilly And Co. (LLY) and Novo Nordisk (NVO) jumped on Friday following reports that the Trump administration is ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and ...